J9042 Brentuximab vedotin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Brentuximab vedotin

Brand Name:

Adcetris

Strength:

1 mg

HCPCS:

J9042

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Drug Antibody Conjugate

Minor Drug Class:

CD30

Oral (Y/N):

No

FDA Approval Year:

2011

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2013

CMS Discontinuation Date:

Status:

In Use